Thermo Fisher Scientific (TMO) Gross Margin (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Gross Margin for 18 consecutive years, with 69.57% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Margin fell 59.0% year-over-year to 69.57%; the trailing twelve-month figure through Jun 2026 stood at 69.78% (down 67.0% YoY), and the FY2025 full-year result was 69.91%, down 57.0% from the prior year.
• Gross Margin held at 69.57% in Q2 2026 per TMO's latest filing, from 69.89% in the prior quarter.
• Across five years, Gross Margin topped out at 71.58% in Q4 2024 and bottomed at 67.28% in Q4 2022.
• Historically, Gross Margin has averaged 69.47% across 5 years, with a median of 69.59% in 2023.
• The widest YoY moves for Gross Margin: up 410 bps in 2022, down 3237 bps in 2022.
• Over 5 years, Gross Margin stood at 67.84% in 2022, then grew by 2 bps to 69.33% in 2023, then increased by 3 bps to 71.58% in 2024, then fell by 3 bps to 69.53% in 2025, then climbed by 0 bps to 69.57% in 2026.
• According to Business Quant data, Gross Margin over the past three periods registered 69.57%, 69.89%, and 69.53% for Q2 2026, Q1 2026, and Q4 2025 respectively.